Detalhe da pesquisa
1.
SARS-CoV-2 Vaccine Immunogenicity in Patients with Gastrointestinal Cancer Receiving Systemic Anti-Cancer Therapy.
Oncologist
; 28(1): e1-e8, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342104
2.
Drug repurposing for COVID-19: current evidence from randomized controlled adaptive platform trials and living systematic reviews.
Br Med Bull
; 147(1): 31-49, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312588
3.
Selective Inhibition of Plasmodium falciparum ATPase 6 by Artemisinins and Identification of New Classes of Inhibitors after Expression in Yeast.
Antimicrob Agents Chemother
; 66(5): e0207921, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35465707
4.
IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Emerg Infect Dis
; 27(1)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256890
5.
Characterisation of the Toxoplasma gondii tyrosine transporter and its phosphorylation by the calcium-dependent protein kinase 3.
Mol Microbiol
; 111(5): 1167-1181, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30402958
6.
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.
N Engl J Med
; 374(17): 1647-60, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25830326
7.
Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.
J Antimicrob Chemother
; 73(3): 581-595, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29237012
8.
GLUT1-mediated glucose uptake plays a crucial role during Plasmodium hepatic infection.
Cell Microbiol
; 19(2)2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27404888
9.
Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial.
PLoS Med
; 14(10): e1002402, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985239
10.
The Plasmodium berghei Ca(2+)/H(+) exchanger, PbCAX, is essential for tolerance to environmental Ca(2+) during sexual development.
PLoS Pathog
; 9(2): e1003191, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23468629
11.
Dealing with change: the different microenvironments faced by the malarial parasite.
Mol Microbiol
; 88(1): 1-4, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23421761
12.
Expression in yeast links field polymorphisms in PfATP6 to in vitro artemisinin resistance and identifies new inhibitor classes.
J Infect Dis
; 208(3): 468-78, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23599312
13.
Susceptibility of human Plasmodium knowlesi infections to anti-malarials.
Malar J
; 12: 425, 2013 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24245918
14.
The QuantuMDx Q-POC SARS-CoV-2 RT-PCR assay for rapid detection of COVID-19 at point-of-care: preliminary evaluation of a novel technology.
Sci Rep
; 13(1): 9827, 2023 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37330592
15.
Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections.
Malar J
; 11: 131, 2012 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22540925
16.
SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests.
Sci Rep
; 12(1): 3351, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233014
17.
Artemisinin Resistance and the Blame Game.
Clin Infect Dis
; 63(8): 1144-5, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27461919
18.
Artemisone uptake in Plasmodium falciparum-infected erythrocytes.
Antimicrob Agents Chemother
; 55(2): 550-6, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21135191
19.
Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle.
Antimicrob Agents Chemother
; 55(6): 2824-30, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21402842
20.
Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa.
Malar J
; 10: 165, 2011 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21676209